Stock Taper
OPPORTUNITY RADAR SCREENER COMPARE ANY 2 STOCKS
CNXU
CONEXEU SCIENCES INC.
NASDAQ
$4.96
▼ DOWN 6.42% (-0.34)

KEY STATISTICS

Market Cap$132.72 M
52w High$18.79
52w Low$4.19
Dividend Yield—
Frequency—
P/E-24.80
Volume608.42K
Shares Out.26.76M

COMPANY

LEADERSHIP

Miles Harrison
CHIEF EXECUTIVE
Miles Harrison

ABOUT

SECTOR
Healthcare
WENT PUBLIC
May 21, 2026
METHOD OF GOING PUBLIC
Direct Listing
FULL TIME EMPLOYEES
4

PRICE TARGET

Target High$20.00
Target Low$20.00
Target Median$20.00
Target Consensus$20.00

UPCOMING EARNINGS

DateSep 30, 2026
DayWednesday
Rev. Est.—
SEP
30
WED

PRICE

$4.96 ▼ DOWN 6.42% (−$0.34)
$4.95$5.10$5.25$5.409:31 AM10:36 AM11:40 AM12:45 PM1:49 PM2:53 PM3:58 PM4.96

About Conexeu Sciences Inc.

www.conexeu.com ↗

Conexeu Sciences Inc. specializes in pioneering regenerative biomaterials intended for various medical fields, including wound management, dental practices, and aesthetic medicine. The enterprise began operations on November 2, 2022, co-founded by Claudia Chavez-Munoz, David R. Bogart, and Ryan Hartwell, and operates from its primary office in Reno, Nevada.

INDUSTRY

Biotechnology

A PRODUCT CONEXEU SCIENCES INC. IS KNOWN FOR

Ten Minute Tissue™
Ten Minute Tissue™

Ten Minute Tissue™ by Conexu Sciences is a temperature-responsive injectable ECM that remains fluid at room temperature and gels in ten minutes at body temperature to support soft tissue regeneration.

COMPETITORS

COMPETITOR
AXGN COMPARE
BVS COMPARE
EOLS COMPARE
IART COMPARE
MESO COMPARE

INSIDER TRADES

★
DIRECTOR
Sharpe Jeffrey Nathan
Purchase · 500.0K shares
2026-09-14
★
DIRECTOR
Sharpe Jeffrey Nathan
Sale · 500.0K shares
2026-09-14
★
DIRECTOR, 10 PERCENT OWNER:
Purcell Lynn Sebastian
Sale · 217.6K shares
2026-09-04
★
DIRECTOR, 10 PERCENT OWNER:
Purcell Lynn Sebastian
Purchase · 217.6K shares
2026-09-04